Join us on the latest episode! Our Guest: Nolan Townsend, CEO of LEXEO TherapeuticsWhat you'll get out of this episode: Can you tell us about your background and what led you to LEXEO? What product candidates are development at LEXEO? How is what LEXEO is developing different than the current treatments in the neurological and cardiac spaces? At BIO you spoke to the topic of accelerated approval, can you provide some perspective on the pathways needed for accelerated approval in gene therapy? How does gene therapy address patient needs across disease areas? What's next? Full Video and more info click here: Slice Of Healthcare Website Our sponsors for this episode are:
Sage Growth Partners https://sage-growth.com/
FlipMD by GoodRX https://www.goodrx.com/
Quantum Health https://quantum-health.com/
To learn more about LEXEO Therapeutics please use the links below:
- LEXEO TX LinkedIN - LEXEO TX Website -